Market Research Reports

All Reports Home

Categories

Countries

Pharmaceuticals Reports

Vietnam Generic Drugs Market, By Type (Small Molecule Generics, Biosimilars), By Mode of Drug Delivery (Oral, Parenteral, Topical, Others), By Form (Tablets, Capsules, Injections, Others), By Source (Contract Manufacturing Organizations, In-house), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, Others), By Application (Neurology, Oncology, Cardiovascular Diseases, Diabetes, Anti-Inflammatory Diseases, Others), By Region, Competition, Forecast & Opportunities, 2020-2030F

Aging Population and the Rising Prevalence of Chronic Diseases and Growth of Healthcare Infrastructure are factors driving the Vietnam Generic Drugs market in Read More

Japan Inflammatory Bowel Disease (IBD) Drugs Market By Disease Type (Crohn’s Disease and Ulcerative Colitis), By Drug Class (TNF Inhibitors, JAK Inhibitors, Aminosalicylates, Corticosteroids, and Others), By Route of Administration (Oral and Parenteral), By End User (Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies), By Region, Competition, Forecast & Opportunities, 2020-2030F

Increasing incidence of IBD and advancements in diagnostic technologies are factors driving the Japan Inflammatory Bowel Disease (IBD) Drugs Market in the Read More

Japan Influenza Medications Market By Type (Antiviral Drugs, Antihistamines, Vaccines, Others), By Route of Administration (Oral, Inhaled), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Region, Competition, Forecast & Opportunities, 2020-2030F

Evolving influenza virus strains and rising incidence of influenza outbreaks are factors driving the Japan Influenza Medications Market in the forecast period Read More

Japan Kidney Cancer Drugs Market By Therapy (Immunotherapy, Chemotherapy, Targeted Therapy), By Drug Class (Monoclonal antibodies, Angiogenesis and mTOR Inhibitors), By Route of Administration (Oral, Intravenous and Subcutaneous), By Distribution Channel (Hospitals, Retail Pharmacies, Others), By Region, Competition, Forecast & Opportunities, 2020-2030F

Rising incidence of renal cell carcinoma (RCC) and advancements in targeted therapies & immunotherapies are factors driving the Japan Kidney Cancer Drugs Market Read More

Japan Lipid Lowering Drugs Market, By Drug (Statins & Combination, PCSK9 Inhibitors, Bile Acid Sequestrants, Fibrates, Cholesterol Absorption Inhibitors, Others), By Indication (Hypercholesterolemia, Coronary Artery Disease, High Triglycerides), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies), By Region, Competition, Forecast & Opportunities, 2020-2030F

Advancements in pharmaceutical research and increasing prevalence of cardiovascular diseases are factors driving the Japan Lipid Lowering Drugs Market in the Read More

Japan Gastrointestinal Drugs Market By Type (Branded and Generics), By Drug Class (Aminosalicylates, Digestive enzymes, Proton Pump Inhibitors, Laxatives, Anti-Emetics, H2 Antagonists, Anti-Diarrheal, Biologics/Biosimilar, and Others), By Application (Crohn’s Disease, Ulcerative Colitis, GERD, IBS), By Route Of Administration (Oral, Injectable, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region, Competition, Forecast & Opportunities, 2020-2030F

Increasing availability and acceptance of over-the-counter (OTC) gastrointestinal medications are factors driving the Japan Gastrointestinal Drugs Market in the Read More

Japan Glaucoma Drugs Market By Indication (Open Angle Glaucoma, Angle Closure Glaucoma, Others), By Drug Class (Prostaglandin Analogs, Beta Blockers, Alpha Agonist, Carbonic Anhydrase Inhibitors, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), By Region, Competition, Forecast & Opportunities, 2020-2030F

Increased prevalence of glaucoma, and advancements in drug therapies are factors driving the Japan Glaucoma Drugs Market in the forecast period 2026-2030.Read More

Japan Gynecology Drugs Market By Therapeutics (Hormonal Therapy and Non-Hormonal Therapy), By Indication (Gynecology Cancers, Menopausal Disorder, Polycystic Ovary Syndrome, Contraception, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Region, Competition, Forecast & Opportunities, 2020-2030F

Expansion of distribution channels and increasing prevalence of gynecological disorders are factors driving the Japan Gynecology Drugs Market in the forecast Read More

Japan Human Insulin Market By Product Type (Rapid-Acting Insulin, Long-Acting Insulin, Combination Insulin, Biosimilars), By Application (Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus), By Type (Human Insulin, Insulin Analog), By Distribution Channel (Hospitals, Retail Pharmacies, and Others), By Region, Competition, Forecast & Opportunities, 2020-2030F

Rising prevalence of diabetes and development of innovative insulin formulations are factors driving the Japan Human Insulin Market in the forecast period Read More

Japan Immunosuppressant Drugs Market By Drug Class (Calcineurin Inhibitors, Antiproliferative Agents, MTOR Inhibitor, Steroids, and Others), By Application (Autoimmune Diseases, Organ Transplant, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Region, Competition, Forecast & Opportunities, 2020-2030F

Innovations in immunosuppressant drug formulations and expanding need for organ transplantation are factors driving the Japan Immunosuppressant Drugs Market in Read More

India Rifampicin Market, By Source (In-house, Contract Manufacturing Organizations), By Form (Tablet, Capsule, Injection), By Route of Administration (Oral, Intravenous), By Distribution Channel (Online, Offline), By Application (Tuberculosis, Leprosy, Legionnaire's Disease, Others), By End User (Adult, Paediatric), By Region, Competition, Forecast & Opportunities, 2020-2030F

High Tuberculosis (TB) Burden and Strong Demand for Fixed-Dose Combination (FDC) Therapies are factors driving the India Rifampicin market in the forecast period Read More

Indonesia Regenerative Medicine Market By Type (Cell Therapy, Gene Modification, Tissue Engineering, Others), By Application (Bone Graft Substitutes, Osteoarticular Diseases, Dermatology, Cardiovascular Diseases, Others), By End User (Academic Institutions and Hospitals & Clinics), By Region, Competition, Forecast and Opportunities, 2020-2030F

Rising Prevalence of Chronic Diseases and Aging Population are factors driving the Indonesia Regenerative Medicine Market in the forecast period, 2026-2030.Read More

UAE Generic Drugs Market By Type (Small Molecule Generics, Biosimilars), By Mode of Drug Delivery (Oral, Topical, Parenteral, Others), By Form (Tablet, Capsule, Injection, Others), By Source (In House, Contract Manufacturing Organizations), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Application (Cardiovascular Diseases, Diabetes, Neurology, Oncology, Anti-Inflammatory Diseases, Others), By Region, Competition, Opportunities & Forecast, 2020-2030F

Increasing Generic Drug Manufacturing and Growing Patient Awareness and Acceptance are expected to drive the demand of UAE Generic Drugs Market in the forecast Read More

Saudi Arabia Breast Cancer Drugs Market By Therapy (Chemotherapy, Immunotherapy, Targeted Therapy, Hormonal Therapy, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Others), By Region and Competition, Forecast & Opportunities, 2020-2030F

Growing prevalence of breast cancer and surge in technological advancements are factors driving the Saudi Arabia Breast Cancer Drugs Market in the forecast Read More

UAE Pharmaceutical Stability & Storage Services Market By Services (Stability testing, Storage), By Molecule (Small Molecule, Large Molecule), By Region, Competition, Forecast and Opportunities, 2020-2030F

Advancements in cold chain logistics and increased healthcare spending and pharmaceutical growth are factors driving the UAE Pharmaceutical Stability & Storage Read More

UAE Pharmaceutical CRO Market By Type (Drug Discovery, Pre-Clinical, Clinical), By Molecule Type (Small Molecules, Large Molecules), By Services (Project Management/Clinical Supply Management, Data Management, Regulatory/Medical Affairs, Medical Writing, Clinical Monitoring, Others), By Therapeutic Areas (Oncology, CNS Disorders, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Other), By Region, Competition, Forecast and Opportunities, 2020-2030F

Growing number of clinical trials and government initiatives and regulatory support are factors driving the UAE Pharmaceutical CRO Market in the forecast period Read More

UAE Pharmaceutical CDMO Market By Product (API, Drug Product), By Workflow (Clinical, Commercial), By Application (Oncology, Infectious Diseases, Neurological Disorders, Cardiovascular Diseases, Metabolic Disorders, Autoimmune Diseases, Respiratory Diseases, Ophthalmology, Gastrointestinal Disorders, Hormonal Disorders, Hematological Disorders, Others), By Region, Competition, Forecast and Opportunities, 2020-2030F

Increasing focus on local manufacturing initiatives and advancements in biologics and biosimilars production are factors driving the UAE Pharmaceutical CDMO Read More

Europe Highly Potent API Market By Type (Innovative High-Potency APIs and Generic High-Potency APIs), By Type of Synthesis (Synthetic and Biological), By Therapeutic Area (Oncology, Immunology, Hormonal Disorders, Infectious Diseases, and Others), By Type of Manufacturing (In-House and Outsourced), By End User (Biopharmaceutical & Life Science Companies, Contract Drug Manufacturing Organizations, and Research Institutions), By Country, Competition, Forecast and Opportunities, 2020-2030F

Rise in complex and targeted therapies requiring potent APIs, coupled with the expanding pipeline of oncology drugs are factors driving the Europe Highly Potent Read More

Saudi Arabia Pharmaceutical CRO Market, By Type (Drug Discovery, Pre-Clinical, Clinical), By Molecular Type (Small Molecules, Large Molecules), By Service (Project Management/Clinical Supply Management, Data Management, Regulatory/Medical Affairs, Medical Writing, Clinical Monitoring, Quality Management/ Assurance, Biostatistics, Investigator Payments, Laboratory, Patient And Site Recruitment, Technology, Others), By Therapeutics Area (Oncology, CNS Disorders, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Respiratory Diseases, Diabetes, Ophthalmology, Pain Management, Other), By Region, Competition, Forecast & Opportunities, 2020-2030F

Rising Prevalence of Chronic Diseases and Increased Investment in R&D are factors driving the Saudi Arabia Pharmaceutical CRO market in the forecast period Read More

Saudi Arabia Pharmaceutical Logistics Market, By Component (Storage, Warehouse, Refrigerated container, Transportation, Sea freight Logistics, Airfreight Logistics, Overland Logistics, Monitoring components, Hardware, Sensors, RFID Devices, Telematics, Networking Devices, Software), By Type (Cold Chain Logistics, Non-Cold Chain Logistics, Conventional Retail Logistics, E-Commerce Retail Logistics, Static, Mobile), By Region, Competition, Forecast & Opportunities, 2020-2030F

Aging Population and Changing Demographics and Healthcare Infrastructure Expansion are factors driving the Saudi Arabia Pharmaceutical Logistics market in the Read More

Prev    Page 22 of 30 Next